Table 2 Choroidal thickness in PNV and partner eyes during follow-up
Baseline choroidal thickness (μm) | Year 1 choroidal thickness (μm) | % reduction | p | Year 2 choroidal thickness (μm) | % reduction | p | |
|---|---|---|---|---|---|---|---|
Eyes with PNV | |||||||
subfoveal | 400.3 ± 57.9 (269–485) | 295.3 ± 52.8 (210–393) | − 0.25 ± 0.14 (− 0.50 to − 0.01) | .00003 | 241.4 ± 52.4 (162–327) | −0.20 ± 0.13 (− 0.38 to − 0.04) | .0003 |
nasal | 311.9 ± 42.1 (243–386) | 249.0 ± 47.2 (180–332) | − 0.19 ± 0.17 (− 0.49 to 0.07) | .0018 | 221.5 ± 40.2 (178–315) | −0.12 ± 0.16 (− 0.35 to 0.15) | .017 |
temporal | 323.9 ± 71.1 (174–404) | 248.6 ± 50.8 (139–316) | −0.23 ± 0.09 (− 0.38 to − 0.02) | < 0.00001 | 219.5 ± 45.8 (108–263) | −0.11 ± 0.15 (− 0.43 to 0.17) | .031 |
Partner eyes | |||||||
subfoveal | 354.5 ± 50.3 (271–425) | 347.5 ± 54.1 (262–403) | −0.02 ± 0.04 (− 0.10 to 0.03) | .19 | 350.5 ± 74.7 (252–449) | −0.01 ± 0.10 (− 0.14 to 0.15) | .48 |
nasal | 264.1 ± 43.8 (183–310) | 257.1 ± 55.7 (158–324) | −0.03 ± 0.13 (− 0.16 to 0.18) | .57 | 266.5 ± 55.1 (183–324) | 0.03 ± 0.12 (− 0.13 to 0.23) | .50 |
temporal | 301.4 ± 50.0 (220–384) | 306.6 ± 56.7 (195–364) | 0.02 ± 0.11 (− 0.12 to 0.16) | .67 | 262.3 ± 33.6 (200–296) | −0.07 ± 0.09 (− 0.17 to 0.07) | .13 |
correlation with number of injections: r = − 0.79; R2 = 0.63; p = .00073 | correlation with number of injections: r = − 0.69; R2 = 0.48; p = .019 | ||||||